|
J Biol Chem, Vol. 274, Issue 44, 31145-31149, October 29, 1999
The N terminus of the Cardiac L-type Ca2+ Channel
1C Subunit
THE INITIAL SEGMENT IS UBIQUITOUS AND CRUCIAL FOR PROTEIN KINASE
C MODULATION, BUT IS NOT DIRECTLY PHOSPHORYLATED*
Elena
Shistik ,
Tal
Keren-Raifman ,
Gregory H.
Idelson§,
Yakov
Blumenstein,
Nathan
Dascal, and
Tatiana
Ivanina¶
From the Department of Physiology and Pharmacology, Sackler School
of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel and the
§ Alomone Labs Ltd., P. O. Box 4287, Jerusalem 91042, Israel
 |
ABSTRACT |
The first 46 amino acids (aa) of the N terminus
of the rabbit heart (RH) L-type cardiac Ca2+ channel
1C subunit are crucial for the stimulating action of protein kinase C (PKC) and also hinder channel gating (Shistik, E.,
Ivanina, T., Blumenstein, Y., and Dascal, N. (1998) J. Biol. Chem. 273, 17901-17909). The mechanism of PKC action and the
location of the PKC target site are not known. Moreover, uncertainties in the genomic sequence of the N-terminal region of 1C
leave open the question of the presence of RH-type N terminus in L-type channels in mammalian tissues. Here, we demonstrate the presence of
1C protein containing an RH-type initial N-terminal
segment in rat heart and brain by using a newly prepared polyclonal
antibody. Using deletion mutants of 1C expressed in
Xenopus oocytes, we further narrowed down the part of the N
terminus crucial for both inhibitory gating and for PKC effect to the
first 20 amino acid residues, and we identify the first 5 aa as an
important determinant of PKC action and of N-terminal effect on gating.
The absence of serines and threonines in the first 5 aa and the absence
of phosphorylation by PKC of a glutathione
S-transferase-fusion protein containing the initial segment
suggest that the effect of PKC does not arise through a direct
phosphorylation of this segment. We propose that PKC acts by
attenuating the inhibitory action of the N terminus via phosphorylation
of a remote site, in the channel or in an auxiliary protein, that
interacts with the initial segment of the N terminus.
 |
INTRODUCTION |
Voltage-dependent L-type Ca2+ channels
regulate contraction of cardiac and smooth muscle and excitability and
gene expression in the brain (2-4). They consist of three subunits:
1 (main, pore-forming subunit), , and
2/ . The 1 subunits in the heart, smooth muscle, and brain are products of the 1C gene
(5). The existence of several cDNA isoforms and the genomic
sequence of the 1C DNA suggest the presence of splice
variants of RNA and thus of several isoforms of the 1C
protein (6-8), but the actual composition of 1C protein
isoforms in tissues is still poorly characterized.
The 1C subunit appears to be the main target for
modulation by protein kinases A and C (PKA and
PKC,1 respectively), although
is also a substrate (9). Both kinases increase the activity of the
channel (10-12). PKC has been proposed to mediate the enhancement of
L-type Ca2+ channels by intracellular ATP (13), angiotensin
II (14), glucocorticoids (15), PACAP (16), and arginine-vasopressin (17). After the initial enhancement by PKC-activating phorbol esters,
the Ca2+ current is often decreased (18, 19), but it is not
clear whether the inhibition is phosphorylation-related (20, 21). The
dual effect of PKC activators is fully reconstituted in
Xenopus oocytes expressing 1C, with or
without 2/ and/or ; the presence of attenuates
the enhancing action of PKC (21, 22). In the nerve cells, either
stimulation (23-26) or inhibition (27-29) of L-type channels by PKC
has been reported.
The 1 subunit is composed of four homologous
membrane-spanning internal domains, each with six transmembrane
-helixes and a pore-forming reentrant P loop (30). C and N termini
and linkers between domains I-II, II-III, and III-IV are cytosolic. The
initial 46 aa of the N terminus of rabbit heart (RH) 1C
are crucial for PKC modulation (1). The cytosolic N-terminal part of RH
1C is 154 aa long. Deletion of the first 40 aa or more
causes a 5-10-fold increase in the current via RH-type
Ca2+ channels expressed in Xenopus oocytes (1,
31). This is a result of a change in channel gating because the
truncation causes an increase in open probability, without increasing
the amount of 1C protein in the plasma membrane (1).
These and additional findings led us to propose that the N terminus of
1C acts as an inhibitory gate, and its removal enhances
channel activation; PKC increases the current by attenuating the
inhibitory action of the N terminus (1). It is not known whether PKC
phosphorylates the N terminus.
Despite the importance of the first 46 aa of the RH-type N terminus,
its presence in L-type channel proteins in vivo remains uncertain. The only other cDNA of 1C containing a
stretch encoding this protein sequence is that cloned from rat aorta
and heart (6). 1C cDNAs cloned from rabbit lung,
human heart, and rat brain (7, 32-34) do not encode this stretch (see
Fig. 2A). It has been proposed that these variations
correspond to splice variants of the 1C gene (7), but
even this is not certain. The structure of the genomic DNA of human
1C has not been fully resolved in this region; none of
the known exons correspond to the RH-type N terminus (8). In contrast,
a recent study that utilized an RNase protection assay showed that RNA
of the RH-type initial segment is predominant in human heart (35).
These discrepancies make it important to clarify whether L-type
Ca2+ channel isoforms with the RH-type N terminus are
common in mammalian tissues.
Here we demonstrate the abundance of the RH-type N terminus in rat
heart and brain and map the segment critical for PKC modulation and for
inhibition of gating to the very beginning of the N terminus. Our
results strongly suggest that PKC effect is not mediated by phosphorylation of this initial segment.
 |
EXPERIMENTAL PROCEDURES |
cDNA Constructs and mRNA--
cDNAs and RNAs of RH
1C and 2/ were as described (1). To
create 1C N-terminal truncations, PCR amplification with
Vent polymerase (New England Biolabs) was performed for
1C N2-5, 1C N2-20, and
1C N2-25, as described for
1C N2-46 and
1C N2-139 (1), introducing a
SalI site followed by an initiation codon (ATG) and then by
the original wild-type (WT) 1C sequence starting from
the desired base (amino acid numbers correspond to the RH
1C sequence (36)).
The cDNA constructs of the GST fusion proteins of the whole N
terminus (N1-154) and of the loop I-II were described previously (1). The cDNAs for N47-154 and
N87-154 (encoding the corresponding 1C
segments) were made by a PCR procedure and inserted into
EcoRI and NotI sites of pGEX-4T-1 (Amersham Pharmacia Biotech) and thus linked in-frame to GST.
N1-46(S44A), with serine 44 replaced by alanine, and a
cDNA for N(neuronal)1-124, encoding aa 1-124 of rat
brain rbCII 1C isoform (7), were inserted into
EcoRI and XhoI sites of pGEX-4T-1. All PCR
products were sequenced at the Tel Aviv University Sequencing Facility. Fusion proteins were generated by transformation into Escherichia coli strain BL-21 (Stratagene) followed by induction with 1 mM isopropyl-1-thio-b-D-galactopyranoside and
affinity purification with GST beads (Amersham Pharmacia Biotech) and
elution with 15 or 20 mM reduced glutathione. In the
preparation of N1-46(S44A), protease inhibitors were used:
aprotinin (10 µg/ml), benzamidine (5 mM), Pefabloc SC
(0.2 mM), and EDTA (1 mM).
N1-46(S44A) was additionally dialyzed to 0.1 M
ammonium acetate buffer, pH 7.0, aliquoted, and lyophilized. Materials
and enzymes for molecular biology were purchased from Roche Molecular
Biochemicals, Promega, or MBI Fermentas.
Oocytes and Electrophysiology--
Xenopus
laevis frogs were maintained and dissected as described (37).
Oocytes were injected with equal amounts (by weight) of the mRNAs
of 1C or its mutants, of 2/ , and, in
the experiment shown in Fig. 2F, of 2A (2.5 ng for
electrophysiological, 5 ng for biochemical experiments) and incubated
for 3-5 days at 20-22 °C in NDE96 solution (96 mM
NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 2.5 mM Na-pyruvate, 50 µg/ml gentamycin, 5 mM HEPES, pH 7.5). Whole cell
currents were recorded using the Gene Clamp 500 amplifier (Axon
Instruments, Foster City, CA) using the two-electrode voltage clamp
technique in a solution containing 40 mM
Ba(OH)2, 50 mM NaOH, 2 mM KOH, and
5 mM HEPES, titrated to pH 7.5 with methanesulfonic acid
(37). Stimulation, data acquisition, and analysis were performed using
pCLAMP software (Axon Instruments). Ba2+ currents were
measured by a 200-ms step to 20 mV from a holding potential of 80 mV.
To study the effect of PMA (10 nM; Sigma), the voltage
pulses were delivered every 10-20 s (see Ref. 1 for details of PMA use).
Antibodies--
Card-I and Card-C antibodies were kindly
provided by M. M. Hosey (Northwestern University, Chicago, IL)
(38). A new antibody (Card-N) was raised against the GST fusion protein
N1-46(S44A). Two New Zealand female rabbits were immunized
with 0.3 mg of N1-46(S44A) in complete Freund's adjuvant,
and reimmunized monthly with 0.2 mg of N1-46(S44A) in
incomplete Freund's adjuvant. Blood samples were taken 10 days after
the immunization. The specific antibodies in the sera were detected by
enzyme-linked immunosorbent assay on immobilized
N1-46(S44A), in the presence of excess of soluble GST (20 µg/ml). The reacting sera were chosen for antibody purification.
Immobilized N1-46S44A, GST, and E. coli lysate were prepared using Affi-Gel 10 (Bio-Rad) according to the
recommendations of the manufacturer. Crude IgG fraction was prepared
from the serum by 50% saturation
(NH4)2SO4 precipitation and
dialyzed in 100 mM Tris-HCl, pH 8.0. To eliminate anti-GST
antibodies, the IgG fraction was incubated with GST beads (Affi-Gel 10, Bio-Rad) overnight at 4 °C. The bound material was eluted with 4.5 M MgCl2. The procedure was repeated with the
unbound material several times until no antibodies were eluted from GST
beads. To eliminate antibodies against possible contaminating bacterial
proteins, the same procedure was performed with immobilized
heat-shocked E. coli lysate proteins. The unbound material
was applied to N1-46S44A-GST beads (Affi-Gel 10, Bio-Rad),
incubated 2 h at room temperature or overnight at 4 °C, and
eluted with 3.5 M MgCl2. The eluted antibodies
were dialyzed against 10 mM Tris-HCl, pH 8.0, and then
against phosphate-buffered saline containing 0.025%
NaN3.
Immunochemistry of the Expressed 1C in Xenopus
Oocytes--
Immunochemistry was performed as described (37). Oocytes
were injected with mRNAs and incubated in NDE solution containing 0.5 mCi/ml [35S]methionine/cysteine (Amersham Pharmacia
Biotech) for 3-4 days at 22 °C. 5 oocytes were homogenized, and
proteins were solubilized, immunoprecipitated, and electrophoresed on
6% polyacrylamide-SDS gel.
Preparation of Tissues and Western Blot Analysis--
Tissues
from 3-week old Wistar rats were frozen in liquid N2,
crushed while frozen, and homogenized on ice in a buffer (0.32 M sucrose, 1 mM EDTA, 50 mM Tris)
containing the Roche Molecular Biochemicals protease inhibitor mixture.
Crude membranes were prepared by centrifugations at 4 °C (two times
at 1100 × g for 10 min to remove the debris and the
nuclei, and then for 1 h at 100,000 × g) and
resuspension of the pellet in the above buffer. The amount of protein
was determined by the Bradford assay. The membranes were stored in
aliquots at 80 °C. Protein samples (35 µg per lane) were
separated on 6% polyacrylamide-SDS gels and transferred to
nitrocellulose membranes for Western blotting with the various antisera
at the following dilutions: Card-C, 1:1000; Card-I, 1:375; Card-N,
1:750 or 1:1000. The filters were visualized using the SuperSignal
Substrate kit (Pierce).
Phosphorylation of GST-Fusion Proteins by PKC--
The procedure
was as described by Kozasa and Gilman (39). 8 µg of each GST-fusion
protein were incubated for 20 min at 30 °C with 1 µl of -,
-, -PKC mixture (Roche Molecular Biochemicals) in 100 µl of 25 mM Tris-HCl (pH 7.5), 5 mM MgCl2,
125 µM CaCl2, 1 mM
dithiothreitol, 10 µM [ -32P]ATP (5000 cpm/pmol), 10 µg/ml phosphatidylserine-diolein (Sigma), 0.05% CHAPS.
The products were precipitated in 3 volumes of ethanol at 20° for
1 h. 32P-radiolabeled fusion proteins were separated
on an 8% acrylamide Laemmli gel containing 0.1% SDS, dried, and
exposed to x-ray film.
 |
RESULTS AND DISCUSSION |
The RH-type N Terminus Is Present in Rat Heart and Brain--
A
polyclonal antibody (Card-N) directed against a GST fusion protein of
the first 46 aa of the RH-type 1C N terminus was raised
in rabbit (since a GST-fusion construct containing the WT 46 aa of RH
1C appeared to degrade in the course of bacterial synthesis, Card-N was actually raised against a more stable fusion protein, N1-46(S44A), in which serine 44 was mutated to alanine). Card-N was compared with two previously characterized antibodies, Card-I (against residues 812-929 of the II-III domain linker) and Card-C (against residues 2156-2169 in the end of the C
terminus) (37, 38). Card-N immunoprecipitated the WT RH 1C protein expressed in Xenopus oocytes and
metabolically labeled with [35S]methionine/cysteine (Fig.
1A, lane 2), but
not the truncated mutant missing the first 46 aa,
1C N2-46 (Fig. 1A, lane 1). Card-I and Card-C immunoprecipitated both the WT
1C and 1C N2-46 (Fig. 1,
A and B); the level of expression of the
full-length 1C was higher than that of
1C N2-46 (Fig. 1B), as
reported previously (1). Card-C precipitated the WT channel more
efficiently than Card-N (Fig. 1A). No
35S-labeled 1C was detected in oocytes that
were not injected with RNA by any of the antibodies (Fig. 1,
A and B). The fact that bands of the same size of
WT 1C are detected by antibodies directed to the extreme
N and C termini and a mid-portion of the channel supports the notion
(37) that the oocyte expresses the whole-length protein not truncated
at any of its termini. Notably, under the conditions used here, the WT
1C protein runs on SDS-polyacrylamide gels as an
~207-kDa band, as reported previously in the oocytes (1, 37). Because
the calculated molecular mass of this protein is ~242 kDa (36), the
error (underestimate) of its size is about 35 kDa. The underestimation
may result from the established fact that hydrophobic proteins tend to
run on SDS-polyacrylamide gels faster than standard, water-soluble
molecular mass markers (40).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 1.
Detecting the Ca2+
channel 1C subunit isoforms
in Xenopus oocytes and in tissues with Card-N, Card-I,
and Card-C antibodies. A, Card-N and Card-C
immunoprecipitate [35S]methionine/cysteine-labeled
1C from oocytes expressing the WT 1C
(lanes 2 and 4) but not from uninjected oocytes
of the same donor (lanes 3 and 5). Card-N fails
to immunoprecipitate 1C N2-46 (lane
1). B, Card-C and Card-I immunoprecipitate
1CWT (lanes 2 and 5) and
1C N2-46 (lanes 3 and
6) from oocytes of one donor injected with the corresponding
RNAs, but not from uninjected oocytes (lanes 1 and
4). In panels A and B,
1C was coexpressed with 2/ . In each
lane, immunoprecipitates from 5 oocytes were loaded. C,
Western blot of rat ventricular membranes with the Card-N antibody in
the absence (lane 2) or presence (lane 1) of the
GST-fusion protein N1-46(S44A). 10 ml of the antibody
(dilution 1:1000) were incubated overnight at 4 °C with 80 µg of
N1-46(S44A), then additional 80 µg were added, and the
antibody/GST fusion protein mixture (lane 1), or 10 ml of
the antibody without N1-46(S44A) (lane 2), were
incubated with the nitrocellulose membranes for 2 h at room
temperature. D, detecting the Ca2+ channel
1C subunit isoforms in ventricle, brain, and liver by
immunoblots with Card-N, Card-I, and Card-C.
|
|
Western blots of rat ventricle membranes with Card-N revealed a major
band at ~207 kDa and a minor band at ~160 kDa; labeling of both
bands was completely suppressed in the presence of the N1-46(S44A) GST-fusion protein against which the antibody was raised (Fig. 1C). This result confirms the specificity
of Card-N and demonstrates, for the first time on the protein level, the presence of an RH-type initial segment in the N terminus of 1C in the rat heart.
Western blots of rat heart (ventricle), brain, and liver were done with
all three antibodies (Fig. 1D). Card-C antibody detected an
~207-kDa band in the ventricle. A higher, ~240-kDa band was observed in all tissues. However, we cannot discard the possibility that this labeling is nonspecific because this band was not detected by
the other two antibodies. The Card-I and Card-N antibodies detected the
~207-kDa band in ventricle and in the brain, although labeling with
Card-I was weak. This may be because of sequence divergence between the
rabbit cardiac 1C and isoforms of rat brain channel that
show variability in the loop II-III (41). With Card-N, the intensity of
this band varied in different blots, and in some instances it was even
stronger in the brain than in the ventricle (data not shown). Because
brain 1C was not detected by Card-C but detected by
Card-N, the very end of the C terminus in a majority of brain
1C protein may be missing or different from the cardiac
one. An additional band at ~160 kDa was detected in the liver by
Card-I and Card-N but not by Card-C; Card-N detected a similar band in
the ventricle. These results support the notion (42) that only a small
percentage of the L-type channel in the heart is truncated at the end
of its C terminus (see also Ref. 43). The actual size of the truncated
protein is probably higher than 160 kDa because of the underestimation
of the size by SDS-polyacrylamide gel electrophoresis in our
conditions. Because 1C RNA has been found in whole liver
but not in hepatocytes (44), the ~160-kDa protein may be present in
nonhepatocyte tissues, e.g. in the blood vessels.
The main conclusion of this part of the study is that 1C
protein containing the RH-type N terminus is present in rat heart and
brain, and the L-type Ca2+ current in these tissues can be
expected to be stimulated by PKC. The variability of PKC effects on
neuronal L-type channels (23-29) may result from the presence of
different isoforms of 1C in different neuronal cell types.
The First Five Amino Acid Residues of 1C Are
Critical for PKC Modulation--
Deletion of the first 46 aa residues
of the 1C, which are unique to the RH-type N terminus
(Fig. 2A), increases the
Ca2+ channel current and also eliminates the PKC-induced
augmentation (1). The effects of deletions shorter than 40 aa have not
been studied (1, 45). To narrow down the segment crucial for PKC effect, we have prepared three additional deletion mutants:
1C N2-5, 1C N2-20, and
1C N2-25, lacking aa 2-5, 2-20, and 2-25, accordingly. All truncated channels produced whole-cell currents
3-10-fold larger than WT in >5 oocyte batches. For a quantitative
comparison, RNAs of WT and of four deletion mutants were prepared on
the same day, in parallel, and injected (together with
2/ subunit) into oocytes of the same donor. Fig.
2B shows that deletion of the first 20 aa was sufficient to
cause a maximal current increase, similar to that produced by the
deletion of 46 or 139 aa. Deletion of aa 2-5 also significantly
(p < 0.01) increased the current but less well than of
20 or more aa. Because coexpression of the 2A subunit increased WT
currents better than those of N-terminal truncation mutants
1C N2-46 and
1C N2-139, we proposed that part of
2A-induced enhancement is because of an allosteric hindrance of the
N-terminal inhibition of gating (1). Fig. 2F shows that the
enhancement of peak currents of 1C N2-5
and 1C N2-20 caused by coexpression of
2A is also weaker than that of the WT channels; this was observed at
all voltages. Thus, the first 20 aa are crucial for the inhibitory effect of the N terminus on L-type channel gating and on its
interaction with 2A, and the first 5 aa constitute an important
component.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 2.
The importance of the initial N-terminal
segment of 1C in modulation of the
channel activity and in mediation of the PKC effect. A,
alignment of protein sequences predicted from cDNA clones from
rabbit heart (36), rat heart (6), and rat brain rbC-II (7). Identical
amino acids are shown by dashes; empty spaces are
gaps introduced for optimal sequence alignment. B,
comparison of Ca2+ channel currents (carried by
Ba2+, IBa) in groups of oocytes of one donor
injected with RNAs of the indicated constructs of 1C,
together with the RNA of 2/ . 8 to 9 oocytes were
tested in each group. Currents were normalized to the mean
IBa measured in the WT group. The increase in
IBa compared with control was significant in all groups
(p < 0.05 or better, ANOVA multiple comparison test
followed by Dunn's test). C, representative current traces
in oocytes of one batch expressing 1CWT or
1C N2-5 (with 2/ )
before and 10 min after the addition of 10 nM PMA.
D, time course of PMA effect on IBa in
representative oocytes of the same donor, expressing
2/ and the indicated construct of 1C.
In each cell, the stability of the current was verified for at least 3 min before the addition of PMA (not shown). PMA addition is shown as
t = 0. E, a summary of the effect of PMA on
channels containing 2/ and either
1CWT, 1C N2-5, or
1C N2-20. Two batches of oocytes, 11 to
12 oocytes in each group. The effect of PMA is presented as percent
increase of IBa in each cell 10 min after the addition of
PMA. Asterisks indicate statistically significant
differences (p < 0.02 or better). F, the
effect of coexpression of 2A subunit on channels containing
2/ and either 1CWT,
1C N2-5, or
1C N2-20 (at +10 mV).
|
|
Fig. 2 shows representative current traces (Fig. 2C) and
time course of the effect of the phorbol ester PMA (Fig. 2D)
in oocytes expressing WT, N2-5, or
N2-20 1C (with the 2/ subunit). Two oocyte batches in which the WT channel showed high sensitivity to PMA, and the Ca2+ channel current was
increased 1.6-4-fold (summarized in Fig. 2E), have been
used in these experiments. The removal of aa 2-5 reduced the PMA
effect by more than 90%; the remaining increase (13 ± 4.4%;
mean ± S.E.) was small but statistically significant (p < 0.02). Channels lacking the first 20 aa were
insensitive to PMA (6.4 ± 8.1%). Thus, the first 5 aa are very
important, and the first 20 aa are crucial for the PKC effect.
PKC Does Not Phosphorylate the Segment Crucial for Its
Physiological Effect--
Based on effects of PKC activators and
inhibitors, the effect of PMA is expected to result from a
PKC-catalyzed phosphorylation (21, 22). Because none of the first 5 aa
of 1C are serines or threonines (Fig. 2A), it
is not possible that PKC directly phosphorylates this segment. None of
the residues in the first 20 aa is a consensus PKC site, but a cryptic
site (T10 or S18) might be a target for PKC.
Therefore, we have examined in vitro phosphorylation by
purified PKC of GST-fusion proteins of segments of the N terminus:
N1-46(S44A), N1-154 (the whole N terminus),
N47-154, and N84-154. As controls, we used
GST and the GST fusion proteins of the loop I-II of RH
1C and of the N terminus of the rat brain
1C, N(neuronal)1-124. Fig.
3 shows that N1-154 and
N47-154 were strongly phosphorylated; weaker signals were
observed in N87-154 and in
N(neuronal)1-124. GST alone, N1-46(S44A), and loop I-II were not phosphorylated. Thus, the first 20 aa, contained within the GST fusion protein N1-46(S44A), are not
phosphorylated under these conditions, whereas other parts of the N
terminus are. The physiological significance of the phosphorylation of these distal parts of the N terminus is unclear at present.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
In vitro phosphorylation of
1C fusion proteins by purified
PKC. GST-fusion proteins of the indicated constructs were
phosphorylated as described under "Experimental Procedures." The
products were resolved by SDS-polyacrylamide gel electrophoresis,
followed by autoradiography.
|
|
In summary, our results demonstrate the presence of 1C
protein isoform(s) containing an RH-type N terminus in rat heart
(ventricle) and brain. Further, we have demonstrated that the initial
20 amino acids are crucial both for the inhibitory gating by the N
terminus, the allosteric interaction of the N terminus with the subunit, and for the PKC effect. Removal of the first 5 aa already
strongly hampers the inhibitory function of the N terminus and almost
fully abolishes the PKC effect. The correlation between the location of
residues crucial for these two functions supports the hypothesis (1)
that PKC exerts its stimulating action by attenuating the inhibition
imposed on the channel by the N terminus.
Determination of the mechanism of PKC action is a challenge for the
future. Our data suggest that the effect of PKC is not attained by a
direct phosphorylation of the initial 20 aa of the N terminus. This
conclusion is supported both by the amino acid composition of this
segment, especially of the first 5 aa crucial for PKC action, and by
the absence of phosphorylation of the GST fusion protein containing the
initial segment. What can be the mechanism of PKC action? There are at
least two possibilities. PKC may phosphorylate a site at
1C which is remote from the initial N-terminal segment
but interacts with it directly or allosterically. If such interaction
is permissive for N-terminal effect on gating (inhibition),
phosphorylation by PKC may weaken the inhibition. Another possibility
is that PKC phosphorylates an auxiliary protein, yet unidentified,
which either aids the N-terminal inhibition (and the phosphorylation
obstructs this effect), or attenuates the N-terminal inhibition when
phosphorylated by PKC.
 |
ACKNOWLEDGEMENTS |
We thank Ilana Lotan and Dafna Singer-Lahat
for many helpful discussions and for the critical reading of the
manuscript, M. Hosey for the gift of Card-C and Card-I antibodies, and
T. P. Snutch for the rbCII cDNA.
 |
FOOTNOTES |
*
This work was supported by a grant from the Israel Academy
of Sciences.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
These authors contributed equally to this work.
¶
To whom correspondence should be addressed. Tel.: (+972) 3 640 9853; Fax: (+972) 3 640 9113; E-mail: dascaln@post.
tau.ac.il.
 |
ABBREVIATIONS |
The abbreviations used are:
PKC, protein kinase
C;
aa, amino acid;
GST, glutathione S-transferase;
PCR, polymerase chain reaction;
PKA, protein kinase A;
PMA, 4- -phorbol
12-myristate 13-acetate;
RH, rabbit heart;
WT, wild-type;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid.
 |
REFERENCES |
| 1.
|
Shistik, E.,
Ivanina, T.,
Blumenstein, Y.,
and Dascal, N.
(1998)
J. Biol. Chem.
273,
17901-17909[Abstract/Free Full Text]
|
| 2.
|
Snutch, T. P.,
and Reiner, P. B.
(1992)
Curr. Opin. Neurobiol.
2,
247-253[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Reuter, H.
(1983)
Nature
301,
569-574[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Finkbeiner, S.,
and Greenberg, M. E.
(1998)
J. Neurobiol.
37,
171-189[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
De Waard, M.,
Gurnett, C. A.,
and Campbell, K. P.
(1996)
Ion Channels
4,
41-87[Medline]
[Order article via Infotrieve]
|
| 6.
|
Koch, W. J.,
Ellinor, P. T.,
and Schwartz, A.
(1990)
J. Biol. Chem.
265,
17786-17791[Abstract/Free Full Text]
|
| 7.
|
Snutch, T. P.,
Tomlinson, W. J.,
Leonard, J. P.,
and Gilbert, M. M.
(1991)
Neuron
7,
45-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Soldatov, N. M.
(1994)
Genomics
22,
77-87[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Puri, T. S.,
Gerhardstein, B. L.,
Zhao, X. L.,
Ladner, M. B.,
and Hosey, M. M.
(1997)
Biochemistry
36,
9605-9615[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Trautwein, W.,
and Hescheler, J.
(1990)
Annu. Rev. Physiol.
52,
257-274[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Tsien, R. W.
(1983)
Annu. Rev. Physiol.
45,
341-358[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Wickman, K.,
and Clapham, D. E.
(1995)
Physiol. Rev.
75,
865-885[Abstract/Free Full Text]
|
| 13.
|
McHugh, D.,
and Beech, D. J.
(1997)
J. Physiol. Lond.
500,
311-317[Abstract/Free Full Text]
|
| 14.
|
Dosemeci, A.,
Dhallan, R. S.,
Cohen, N. M.,
Lederer, W. J.,
and Rogers, T. B.
(1988)
Circ. Res.
62,
347-357[Abstract/Free Full Text]
|
| 15.
|
Kato, H.,
Hayashi, T.,
Koshino, Y.,
Kutsumi, Y.,
Nakai, T.,
and Miyabo, S.
(1992)
Biochem. Biophys. Res. Commun.
188,
934-941[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Chik, C. L.,
Li, B.,
Ogiwara, T.,
Ho, A. K.,
and Karpinski, E.
(1996)
FASEB J.
10,
1310-1317[Abstract]
|
| 17.
|
Zhang, S.,
Hirano, Y.,
and Hiraoka, M.
(1995)
Circ. Res.
76,
592-599[Abstract/Free Full Text]
|
| 18.
|
Lacerda, A. E.,
Rampe, D.,
and Brown, A. M.
(1988)
Nature
335,
249-251[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Tseng, G. N.,
and Boyden, P. A.
(1991)
Am. J. Physiol.
261,
H364-H379[Abstract/Free Full Text]
|
| 20.
|
Asai, T.,
Shuba, L. M.,
Pelzer, D. J.,
and McDonald, T. F.
(1996)
Am. J. Physiol.
270,
H620-H627[Abstract/Free Full Text]
|
| 21.
|
Bourinet, E.,
Fournier, F.,
Lory, P.,
Charnet, P.,
and Nargeot, J.
(1992)
Pfluegers Arch.
421,
247-255[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Singer-Lahat, D.,
Gershon, E.,
Lotan, I.,
Hullin, R.,
Biel, M.,
Flockerzi, V.,
Hofmann, F.,
and Dascal, N.
(1992)
FEBS Lett.
306,
113-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Yang, J.,
and Tsien, R. W.
(1993)
Neuron
10,
127-136[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Kleppisch, T.,
Klinz, F. J.,
and Hescheler, J.
(1992)
Brain Res.
591,
283-288[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Herman, M. D.,
Reuveny, E.,
and Narahashi, T.
(1993)
J. Physiol. (Lond).
462,
645-660[Abstract/Free Full Text]
|
| 26.
|
Hall, K. E.,
Browning, M. D.,
Dudek, E. M.,
and Macdonald, R. L.
(1995)
J. Neurosci.
15,
6069-6076[Abstract]
|
| 27.
|
Hsu, K. S.,
Huang, C. C.,
Kan, W. M.,
and Gean, P. W.
(1996)
Am. J. Physiol.
271,
C1269-C1277[Abstract/Free Full Text]
|
| 28.
|
ffrench-Mullen, J. M.
(1995)
J. Neurosci.
15,
903-911[Abstract]
|
| 29.
|
Doerner, D.,
Pitler, T. A.,
and Alger, B. E.
(1988)
J. Neurosci.
8,
4069-4078[Abstract]
|
| 30.
|
Catterall, W. A.
(1993)
Trends Neurosci.
16,
500-506[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Wei, X.,
Neely, A.,
Olcese, R.,
Lang, W.,
Stefani, E.,
and Birnbaumer, L.
(1996)
Recept. Channels
4,
205-215[Medline]
[Order article via Infotrieve]
|
| 32.
|
Schultz, D.,
Mikala, G.,
Yatani, A.,
Engle, D. B.,
Iles, D. E.,
Segers, B.,
Sinke, R. J.,
Weghuis, D. O.,
Klockner, U.,
Wakamori, M.,
Wang, J. J.,
Melvin, D.,
Varadi, G.,
and Schwartz, A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
6228-6232[Abstract/Free Full Text]
|
| 33.
|
Bouron, A.,
Soldatov, N. M.,
and Reuter, H.
(1995)
FEBS Lett.
377,
159-162[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Biel, M.,
Ruth, P.,
Bosse, E.,
Hullin, R.,
Stuhmer, W.,
Flockerzi, V.,
and Hofmann, F.
(1990)
FEBS Lett.
269,
409-412[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Yang, Y.,
Chen, X.,
and Houser, S. P.
(1999)
Biophys. J.
76,
A431
|
| 36.
|
Mikami, A.,
Imoto, K.,
Tanabe, T.,
Niidome, T.,
Mori, Y.,
Takeshima, H.,
Narumiya, S.,
and Numa, S.
(1989)
Nature
340,
230-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Shistik, E.,
Ivanina, T.,
Puri, T.,
Hosey, M.,
and Dascal, N.
(1995)
J. Physiol. (Lond.)
489,
55-62[Abstract/Free Full Text]
|
| 38.
|
Chien, A. J.,
Zhao, X.,
Shirokov, R. E.,
Puri, T. S.,
Chang, C. F.,
Sun, D.,
Rios, E.,
and Hosey, M. M.
(1995)
J. Biol. Chem.
270,
30036-30044[Abstract/Free Full Text]
|
| 39.
|
Kozasa, T.,
and Gilman, A. G.
(1996)
J. Biol. Chem.
271,
12562-12567[Abstract/Free Full Text]
|
| 40.
|
Takagi, T.
(1991)
Adv. Electrophoresis
4,
391-406
|
| 41.
|
Khan, I.,
Ahmad, S.,
and Thomas, N.
(1998)
Biochem. Mol. Biol. Int.
45,
895-904[Medline]
[Order article via Infotrieve]
|
| 42.
|
Gao, T.,
Puri, T. S.,
Gerhardstein, B. L.,
Chien, A. J.,
Green, R. D.,
and Hosey, M. M.
(1997)
J. Biol. Chem.
272,
19401-19407[Abstract/Free Full Text]
|
| 43.
|
Yoshida, A.,
Takahashi, M.,
Nishimura, S.,
Takeshima, H.,
and Kokubun, S.
(1992)
FEBS Lett.
309,
343-349[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Brereton, H. M.,
Harland, M. L.,
Froscio, M.,
Petronijevic, T.,
and Barritt, G. J.
(1997)
Cell Calcium
22,
39-52[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Wei, X.,
Pan, S.,
Lang, W.,
Kim, H.,
Schneider, T.,
Perez Reyes, E.,
and Birnbaumer, L.
(1995)
J. Biol. Chem.
270,
27106-27111[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Dai, D. D. Hall, and J. W. Hell
Supramolecular Assemblies and Localized Regulation of Voltage-Gated Ion Channels
Physiol Rev,
April 1, 2009;
89(2):
411 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Leary, S. Rajasekaran, R. R. Morrison, E. I. Tuomanen, T. K. Chin, and P. A. Hofmann
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation
Am J Physiol Heart Circ Physiol,
June 1, 2008;
294(6):
H2775 - H2784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. D. J. ter Keurs and P. A. Boyden
Calcium and Arrhythmogenesis
Physiol Rev,
April 1, 2007;
87(2):
457 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Baroudi, Y. Qu, O. Ramadan, M. Chahine, and M. Boutjdir
Protein kinase C activation inhibits Cav1.3 calcium channel at NH2-terminal serine 81 phosphorylation site.
Am J Physiol Heart Circ Physiol,
October 1, 2006;
291(4):
H1614 - H1622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kanevsky and N. Dascal
Regulation of Maximal Open Probability Is a Separable Function of Cav{beta} Subunit in L-type Ca2+ Channel, Dependent on NH2 Terminus of {alpha}1C (Cav1.2{alpha})
J. Gen. Physiol.,
June 26, 2006;
128(1):
15 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gui, X. Wu, S. Ling, S. C. Stotz, R. J. Winkfein, E. Wilson, G. E. Davis, A. P. Braun, G. W. Zamponi, and M. J. Davis
Integrin Receptor Activation Triggers Converging Regulation of Cav1.2 Calcium Channels by c-Src and Protein Kinase A Pathways
J. Biol. Chem.,
May 19, 2006;
281(20):
14015 - 14025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Liao, T. F. Yong, M. C. Liang, D. T. Yue, and T. W. Soong
Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles
Cardiovasc Res,
November 1, 2005;
68(2):
197 - 203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, G. Liu, S. I. Zakharov, J. P. Morrow, V. O. Rybin, S. F. Steinberg, and S. O. Marx
Ser1928 Is a Common Site for Cav1.2 Phosphorylation by Protein Kinase C Isoforms
J. Biol. Chem.,
January 7, 2005;
280(1):
207 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A.G. van der Heyden, T. J.M. Wijnhoven, and T. Opthof
Molecular aspects of adrenergic modulation of cardiac L-type Ca2+ channels
Cardiovasc Res,
January 1, 2005;
65(1):
28 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Liao, D. Yu, S. Lu, Z. Tang, M. C. Liang, S. Zeng, W. Lin, and T. W. Soong
Smooth Muscle-selective Alternatively Spliced Exon Generates Functional Variation in Cav1.2 Calcium Channels
J. Biol. Chem.,
November 26, 2004;
279(48):
50329 - 50335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Z. Tang, M. C. Liang, S. Lu, D. Yu, C. Y. Yu, D. T. Yue, and T. W. Soong
Transcript Scanning Reveals Novel and Extensive Splice Variations in Human L-type Voltage-gated Calcium Channel, Cav1.2 {alpha}1 Subunit
J. Biol. Chem.,
October 22, 2004;
279(43):
44335 - 44343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Korzick, M. H. Laughlin, and D. K. Bowles
Alterations in PKC signaling underlie enhanced myogenic tone in exercise-trained porcine coronary resistance arteries
J Appl Physiol,
April 1, 2004;
96(4):
1425 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Weiss, T. Doan, K. E. Bernstein, and N. Dascal
Modulation of Cardiac Ca2+ Channel by Gq-activating Neurotransmitters Reconstituted in Xenopus Oocytes
J. Biol. Chem.,
March 26, 2004;
279(13):
12503 - 12510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Kamatchi, R. Franke, C. Lynch III, and J. J. Sando
Identification of Sites Responsible for Potentiation of Type 2.3 Calcium Currents by Acetyl-{beta}-methylcholine
J. Biol. Chem.,
February 6, 2004;
279(6):
4102 - 4109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Young and C. R. Yang
Dopamine D1/D5 Receptor Modulates State-Dependent Switching of Soma-Dendritic Ca2+ Potentials via Differential Protein Kinase A and C Activation in Rat Prefrontal Cortical Neurons
J. Neurosci.,
January 7, 2004;
24(1):
8 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Protas, A. Barbuti, J. Qu, V. O. Rybin, R. D. Palmiter, S. F. Steinberg, and R. B. Robinson
Neuropeptide Y Is an Essential In Vivo Developmental Regulator of Cardiac ICa,L
Circ. Res.,
November 14, 2003;
93(10):
972 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Lin, P.-W. Zhang, X. Zhu, J.-M. Melgari, R. Huff, R. L. Spieldoch, and G. R. Uhl
Phosphatidylinositol 3-Kinase, Protein Kinase C, and MEK1/2 Kinase Regulation of Dopamine Transporters (DAT) Require N-terminal DAT Phosphoacceptor Sites
J. Biol. Chem.,
May 23, 2003;
278(22):
20162 - 20170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B Walsh and G. E Parks
Changes in cardiac myocyte morphology alter the properties of voltage-gated ion channels
Cardiovasc Res,
July 1, 2002;
55(1):
64 - 75.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Blumenstein, N. Kanevsky, G. Sahar, R. Barzilai, T. Ivanina, and N. Dascal
A Novel Long N-terminal Isoform of Human L-type Ca2+ Channel Is Up-regulated by Protein Kinase C
J. Biol. Chem.,
January 25, 2002;
277(5):
3419 - 3423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Keef, J. R. Hume, and J. Zhong
Regulation of cardiac and smooth muscle Ca2+ channels (CaV1.2a,b) by protein kinases
Am J Physiol Cell Physiol,
December 1, 2001;
281(6):
C1743 - C1756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Davis, X. Wu, T. R. Nurkiewicz, J. Kawasaki, P. Gui, M. A. Hill, and E. Wilson
Regulation of ion channels by protein tyrosine phosphorylation
Am J Physiol Heart Circ Physiol,
November 1, 2001;
281(5):
H1835 - H1862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. McHugh, E. M. Sharp, T. Scheuer, and W. A. Catterall
Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain
PNAS,
October 12, 2000;
(2000)
210384297.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Ivanina, Y. Blumenstein, E. Shistik, R. Barzilai, and N. Dascal
Modulation of L-type Ca2+ Channels by Gbeta gamma and Calmodulin via Interactions with N and C Termini of alpha 1C
J. Biol. Chem.,
December 15, 2000;
275(51):
39846 - 39854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. McHugh, E. M. Sharp, T. Scheuer, and W. A. Catterall
Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain
PNAS,
October 24, 2000;
97(22):
12334 - 12338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Alden, P. H. Goldspink, S. W. Ruch, P. M. Buttrick, and J. Garcia
Enhancement of L-type Ca2+ current from neonatal mouse ventricular myocytes by constitutively active PKC-beta II
Am J Physiol Cell Physiol,
April 1, 2002;
282(4):
C768 - C774.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|